Johnson & Johnson (JNJ) Stock: Surge as FDA Clearance Boosts MONARCH QUEST 3 Expansion 

TLDR JNJ stock gains as FDA clears MONARCH QUEST 3 bronchoscopy software update. MONARCH QUEST 3 adds AI-powered planning and stronger navigation capabilities. Johnson & Johnson expands CBCT imaging support across the MONARCH Platform. Polyphonic integration adds smarter procedure review tools for clinical teams. FDA clearance supports broader MONARCH use in advanced lung diagnostic care. [...]

The post Johnson & Johnson (JNJ) Stock: Surge as FDA Clearance Boosts MONARCH QUEST 3 Expansion  appeared first on Blockonomi.